IL160194A0 - GLYCINE-SUBSTITUTED THIENO [2,3-d] PYRIMIDINE WITH COMBINED LH AND FSH AGONISTIC ACTIVITY - Google Patents

GLYCINE-SUBSTITUTED THIENO [2,3-d] PYRIMIDINE WITH COMBINED LH AND FSH AGONISTIC ACTIVITY

Info

Publication number
IL160194A0
IL160194A0 IL16019402A IL16019402A IL160194A0 IL 160194 A0 IL160194 A0 IL 160194A0 IL 16019402 A IL16019402 A IL 16019402A IL 16019402 A IL16019402 A IL 16019402A IL 160194 A0 IL160194 A0 IL 160194A0
Authority
IL
Israel
Prior art keywords
pyrimidine
glycine
combined
agonistic activity
substituted thieno
Prior art date
Application number
IL16019402A
Other languages
English (en)
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL160194A0 publication Critical patent/IL160194A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL16019402A 2001-09-04 2002-08-29 GLYCINE-SUBSTITUTED THIENO [2,3-d] PYRIMIDINE WITH COMBINED LH AND FSH AGONISTIC ACTIVITY IL160194A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01203328 2001-09-04
PCT/EP2002/009648 WO2003020727A1 (en) 2001-09-04 2002-08-29 GLYCINE-SUBSTITUTED THIENO [2,3-d]PYRIMIDINES WITH COMBINED LH AND FSH AGONISTIC ACTIVITY

Publications (1)

Publication Number Publication Date
IL160194A0 true IL160194A0 (en) 2004-07-25

Family

ID=8180877

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16019402A IL160194A0 (en) 2001-09-04 2002-08-29 GLYCINE-SUBSTITUTED THIENO [2,3-d] PYRIMIDINE WITH COMBINED LH AND FSH AGONISTIC ACTIVITY
IL160194A IL160194A (en) 2001-09-04 2004-02-03 Theano [2,3 – d] glycine-converted pyrimidines with combined LH and FSH agonist activity

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL160194A IL160194A (en) 2001-09-04 2004-02-03 Theano [2,3 – d] glycine-converted pyrimidines with combined LH and FSH agonist activity

Country Status (27)

Country Link
US (1) US7375109B2 (xx)
EP (1) EP1427734B1 (xx)
JP (1) JP4263094B2 (xx)
KR (1) KR100891630B1 (xx)
CN (1) CN1261437C (xx)
AR (1) AR036408A1 (xx)
AT (1) ATE309251T1 (xx)
AU (1) AU2002333750B2 (xx)
BR (1) BR0212173A (xx)
CA (1) CA2457212C (xx)
CY (1) CY1106052T1 (xx)
DE (1) DE60207280T2 (xx)
DK (1) DK1427734T3 (xx)
EC (1) ECSP044990A (xx)
ES (1) ES2252540T3 (xx)
HR (1) HRP20040194A2 (xx)
HU (1) HUP0401443A3 (xx)
IL (2) IL160194A0 (xx)
IS (1) IS2419B (xx)
MX (1) MXPA04002046A (xx)
NO (1) NO328792B1 (xx)
NZ (1) NZ531375A (xx)
PE (1) PE20030467A1 (xx)
PL (1) PL368388A1 (xx)
RU (1) RU2294331C2 (xx)
WO (1) WO2003020727A1 (xx)
ZA (1) ZA200401459B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890923B2 (en) * 2002-12-16 2005-05-10 Astrazeneca Ab Compounds
KR100666484B1 (ko) * 2005-02-04 2007-01-09 삼성전자주식회사 반도체 메모리 장치의 입출력 회로 및 입출력 방법
JP5718233B2 (ja) 2008-10-20 2015-05-13 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ 甲状腺刺激ホルモン受容体（ｔｓｈｒ）の低分子量アゴニスト
CN101762915B (zh) * 2008-12-24 2013-04-17 北京京东方光电科技有限公司 Tft-lcd阵列基板及其驱动方法
EP2563777A4 (en) 2010-04-08 2013-09-04 Us Health INVERSE AGONISTS AND NEUTRAL AGONISTS FOR THE TSH RECEPTOR
SI3415517T1 (sl) * 2012-09-28 2022-06-30 Takeda Pharmaceutical Company Limited Kristalna oblika 1-(4-1-(2,6-difluorobenzil)-5-dimetilaminometil-3-(6- metoksipiridazin-3-il)-2,4-diokso-1,2,3,4-tetrahidrotieno(2,3-D)- pirimidin-6il)fenil)-3-metoksiurea

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE86484T1 (de) 1987-08-08 1993-03-15 Akzo Nv Kontrazeptives implantat.
TW564247B (en) * 1999-04-08 2003-12-01 Akzo Nobel Nv Bicyclic heteraromatic compound

Also Published As

Publication number Publication date
ATE309251T1 (de) 2005-11-15
CY1106052T1 (el) 2011-04-06
ECSP044990A (es) 2004-04-28
KR100891630B1 (ko) 2009-04-03
WO2003020727A1 (en) 2003-03-13
BR0212173A (pt) 2004-07-20
US7375109B2 (en) 2008-05-20
CN1261437C (zh) 2006-06-28
IS7152A (is) 2004-02-13
PL368388A1 (en) 2005-03-21
MXPA04002046A (es) 2004-07-16
HRP20040194A2 (en) 2004-08-31
NO328792B1 (no) 2010-05-18
ZA200401459B (en) 2004-11-22
US20040180907A1 (en) 2004-09-16
AU2002333750B2 (en) 2008-02-21
CA2457212A1 (en) 2003-03-13
RU2004110036A (ru) 2005-10-10
NZ531375A (en) 2005-06-24
AR036408A1 (es) 2004-09-08
HUP0401443A3 (en) 2008-05-28
JP4263094B2 (ja) 2009-05-13
IS2419B (is) 2008-10-15
CA2457212C (en) 2011-02-15
DE60207280D1 (de) 2005-12-15
IL160194A (en) 2009-06-15
CN1551883A (zh) 2004-12-01
HUP0401443A2 (hu) 2004-11-29
EP1427734A1 (en) 2004-06-16
KR20040029135A (ko) 2004-04-03
NO20040922L (no) 2004-03-03
JP2005504784A (ja) 2005-02-17
PE20030467A1 (es) 2003-05-26
EP1427734B1 (en) 2005-11-09
ES2252540T3 (es) 2006-05-16
RU2294331C2 (ru) 2007-02-27
DK1427734T3 (da) 2006-03-06
DE60207280T2 (de) 2006-05-18

Similar Documents

Publication Publication Date Title
IL159832A0 (en) 4-amino-6-phenyl-pyrrolo[2,3-d] pyrimidine derivatives
EP1401840A4 (en) NEW 4-AMINO-5,6-SUBSTITUTED THIOPHENO 2,3 D | PYRIMIDINE
IL151849A0 (en) Pyrido [2,3-d] pyrimidine and pyrimido [4,5-d] pyrimidine nucleosides
EG24399A (en) Pyrrolo[2,3-D]pyrimidine compounds
IL158697A0 (en) 4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-d) pyrimidine derivatives
IL159507A0 (en) Substituted dihydro 3-halo-1h pyrazole-5-carboxylates, their preparation and use
IL175433A0 (en) 5,7 diaminopyrazolo [4,3-d] pyrimidines with pde-5 inhibiting activity
HK1078574A1 (en) Pyrazolo [4,3-D] pyrimidine derivatives
IL147908A0 (en) PYRROLO[2,3-d] PYRIMIDINE NUCLEOSIDE ANALOGS
IL160084A0 (en) Thieno [2,3-d] pyrimidines with combined la and fsh agonistic activity
PL358551A1 (en) 5-aminoalkyl-pyrazolo[4,3-d]pyrimidines
AU2001279700A1 (en) 5-aminoalkyl-pyrazolo(4,3-d)pyrimidines with a phosphodiesterase v-inhibiting effect
IL160194A0 (en) GLYCINE-SUBSTITUTED THIENO [2,3-d] PYRIMIDINE WITH COMBINED LH AND FSH AGONISTIC ACTIVITY
HUP0303005A3 (en) Pharmaceutical compositions comprising pyrazolo[4,3-d]pyrimidines or thienopyrimidines and endothelin receptor antagonists
MXPA03004498A (es) Uso de pirazolo (4,3-d)pirimidinas.
MXPA03004907A (es) Uso de pirazolo (4,3-d) pirimidinas.
AU8578501A (en) 2-aminoalkyl-thieno(2,3-d)pyrimidines
AU2001285785A1 (en) 2-aminoalkyl-thieno[2,3-d]pyrimidines
GB0130695D0 (en) Pyrazola[4,3]pyrimidine
AU2002217336A1 (en) Thieno(3,2-d)pyrimidines and furano(3,2-d)pyrimidines and their use as purinergic receptor antagonists
AU2002305292A1 (en) Novel 4-amino-5,6-substituted thiopheno(2,3-d)pyrimidines
TW535943U (en) Mouse with wireless receiving function
CA93906S (en) Umbrella cookie die